Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats.

Source:http://linkedlifedata.com/resource/pubmed/id/17707397

Download in:

View as

General Info

PMID
17707397